← Open Payments lookup

KATHLEEN RAIS: Open Payments

NPI 1366601437 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$8,089 in 384 payments from 26 companies in 2025. Trend: 2023 $4,918 · 2024 $5,977 · 2025 $8,089

Food & beverage: $6,335Consulting: $1,370Education: $385
CompanyPaymentsAmount
Regeneron Pharmaceuticals, Inc.4$1,391
ABBVIE INC.56$835
UCB, Inc.25$704
Janssen Biotech, Inc.30$672
PFIZER INC.26$533
Regeneron Healthcare Solutions, Inc.26$514
Galderma Laboratories, L.P.24$359
SUN PHARMACEUTICAL INDUSTRIES INC.20$341
Arcutis Biotherapeutics, Inc.20$333
Incyte Corporation23$325

Products named: DUPIXENT, Bimzelx, TREMFYA, CIBINQO, RINVOQ, SKYRIZI, Zoryve, OPZELURA.

Industry payments across TX — which companies pay providers there.